Amendment: SEC Form SCHEDULE 13D/A filed by Altisource Portfolio Solutions S.A.
$ASPS
Other Consumer Services
Consumer Discretionary
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 2)
|
ALTISOURCE PORTFOLIO SOLUTIONS S.A. (Name of Issuer) |
Common Stock, par value $0.01 per share (Title of Class of Securities) |
L0175J104 (CUSIP Number) |
Peter C. Gyr
UBS Asset Management (Americas) LLC, 1285 Avenue of the Americas, 11th Floor
New York, NY, 10019
212-713-3123
UBS Asset Management (Americas) LLC, 1285 Avenue of the Americas, 11th Floor
New York, NY, 10019
212-713-3123
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
01/16/2026
(Date of Event Which Requires Filing of This Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other
provisions of the Act (however, see the Notes).
SCHEDULE 13D
|
| CUSIP Number(s): | L0175J104 |
| 1 |
Name of reporting person
Credit Investments Group, a distinct business unit of UBS Asset Management (Americas) LLC | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
 (b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
OO | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
2,689,527.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
23.4 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IA |
SCHEDULE 13D
|
| Item 1. | Security and Issuer | |
| (a) | Title of Class of Securities:
Common Stock, par value $0.01 per share | |
| (b) | Name of Issuer:
ALTISOURCE PORTFOLIO SOLUTIONS S.A. | |
| (c) | Address of Issuer's Principal Executive Offices:
33, BOULEVARD PRINCE HENRI, L-1724 LUXEMBOURG CITY, GRAND DUCHY OF LUXEMBOURG,
LUXEMBOURG
, L-1724. | |
Item 1 Comment:
This Amendment No. 2 (this "Amendment") amends and supplements the statement on Schedule 13D originally filed with the Securities and Exchange Commission (the "SEC") on February 26, 2025 as amended by Amendment No. 1 filed on April 7, 2025 (as amended by this Amendment, the "Schedule 13D") with respect to shares of Common Stock, par value $0.01 per share ("Common Stock"), of the Issuer. Unless indicated otherwise, all items left blank remain unchanged and any items which are reported are deemed to amend and supplement the existing items in the Schedule 13D. Capitalized terms used herein and not otherwise defined in this Amendment shall have the meanings ascribed to them in the Schedule 13D. | ||
| Item 2. | Identity and Background | |
| (b) | The business address of the Reporting Person and each Covered Person at UBS Asset Management (Americas) LLC is 1285 Avenue of the Americas, 11th Floor, New York, NY 10019. | |
| Item 4. | Purpose of Transaction | |
On January 16, 2026, the Client Accounts sold an aggregate of 2,108 shares of Common Stock (which represents 0.018% of the outstanding shares of Common Stock).
The Reporting Person intends to evaluate on an ongoing basis its investment in the Issuer and its options with respect to such investment. Depending on market conditions, an evaluation of the business and the prospect of the Issuer and other factors, the Reporting Person may, in its sole discretion, purchase additional shares of Common Stock, or other securities convertible into or exchangeable for shares of Common Stock, and/or other equity, debt, notes instruments or other securities of the Issuer, dispose of shares of Common Stock or such other securities from time to time in the open market, in privately negotiated transactions or otherwise, and/or otherwise change its intention with respect to any and all matters referred to in this Item 4.
Except as set forth herein, the Reporting Person does not have, as of the date of this Schedule 13D, any plans or proposals that relate to or would result in any of the actions or events specified in clauses (a) through (j) of Item 4 of Schedule 13D. However, the Reporting Person reserves the right to adopt such plans or proposals in the future, subject to applicable regulatory requirements, if any. | ||
| Item 5. | Interest in Securities of the Issuer | |
| (a) | The Client Accounts are the direct holders of an aggregate of 2,689,527 shares of Common Stock, constituting approximately 23.4% of the outstanding Common Stock, including Cash Exercise Warrants exercisable for 112,133 shares of Common Stock and Cashless Exercise Warrants exercisable for 112,133 shares of Common Stock. The foregoing percentage is calculated based on 11,278,949 shares of Common Stock outstanding as of April 17, 2026 (as reported by the Issuer in the Quarterly Report on Form 10-Q filed with the SEC on April 23, 2026) and an aggregate of 224,266 shares of Common Stock issuable upon exercise of the Warrants. For purposes of the calculations in this Schedule 13D, we have assumed that all of the shares of Common Stock underlying the Cashless Exercise Warrants are beneficially owned; however, the number of shares of Common Stock issuable upon the exercise of Cashless Exercise Warrants will depend on the price of the Common Stock at the time of exercise, and fewer than all of the shares of Common Stock underlying the Cash Exercise Warrants will be issued upon any exercise thereof. The information as to the number of shares of Common Stock (and shares issuable upon exercise of the Warrants) in this Amendment have been retroactively adjusted to give effect to a 1-for-8 reverse stock split of the Common Stock, effective as of May 28, 2025. | |
| (b) | See rows (7) through (10) of the cover page to this Schedule 13D, which are incorporated herein by reference. | |
| (c) | The Client Accounts have not engaged in any transactions in shares of Common Stock during the past sixty days. | |
| (d) | Except for the Client Accounts which are the direct holders of the Shares, no other person is known by the Reporting Person to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, any shares of Common Stock that may be beneficially owned by the Reporting Person. | |
| (e) | Not Applicable. | |
| Item 6. | Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer | |
Item 6 of the Schedule 13D is hereby supplemented by incorporating by reference in its entirety the information set forth in Item 4 above. | ||
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|